Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Researchers create CAR T cells for cancer immunotherapy

In CAR T-cell immunotherapy, T cells taken from the patient’s own blood are modified to contain so-called chimeric antigen receptors (CAR), which provide the T cells the ability to target and eradicate tumor cells.

8 Aug 2022

New sample pre-treatment method enables efficient protein recovery

The cells’ proteins contain a huge world of information that, when unlocked, can shed light on the causes of many fundamental biological occurrences. To observe the properties of individual cells at the protein level, a single-cell analysis method known as “single-cell proteomics” is used.

8 Aug 2022

Optogenetic control of mitochondria–lysosome contacts induce mitochondrial fission with spatiotemporal accuracy

Researchers from UC, the University of Illinois Urbana-Champaign, and the University at Buffalo demonstrated that light-activated proteins can help normalize dysfunction within cells.

8 Aug 2022

Research findings likely to help identify key differences between effective and flawed immune systems

T cells, a special class of white blood cells, defend the body and kill infected or foreign tissue. In an organ called the thymus, they learn to distinguish between proteins that are helpful and those that are harmful.

8 Aug 2022

SLFN11’s surveillance part in protein homeostasis

On July 25th, 2022, a new study perspective called “SLFN11’s surveillance role in protein homeostasis” was published in Volume 9 of Oncoscience.

8 Aug 2022

Researchers develop targeted immunotherapy to destroy tumor cells

A minimally invasive technique was created and improved by scientists at Terasaki Institute for Biomedical Innovation (TIBI) to develop immunotherapeutic cancer treatments.

3 Aug 2022

Senior leadership positions at cancer centers lack diversity, survey reveals

A new national survey reveals a dramatic lack of diversity in senior leadership positions at the nation's cancer centers.

29 Jul 2022

Scientists determine the contribution of DNA recombinations to genomic diversity in health and disease

Researchers from Japan’s RIKEN Center for Integrative Medical Sciences, working with colleagues from all over the world, found that recombinations of particular genomic sequences, which are reproduced millions of times in the genome of each human cell, are common in both normal and disease states.

28 Jul 2022

Scientists discover cells travel faster through mucus than blood

Some cells travel quicker in thicker fluids, such as honey against water or mucus versus blood, because their ruffled edges detect the viscosity of their surroundings and adjust to boost their speed.

From University of Toronto 28 Jul 2022

New method can easily convert commercially available DNA chips into RNA chips

Biochips (microarrays) are modern analytical tools that allow thousands of individual detections to be performed simultaneously in a small amount of sample material. A team led by Mark Somoza from the Faculty of Chemistry at the University of Vienna has now presented a new method in "Nature Communications".

27 Jul 2022

Researchers find immune-effective ways to destroy cancer cells

Treatment with chimeric antigen receptor T cells (CAR T cells) is often the last hope for patients with lymphoma, multiple myeloma, or certain kinds of leukemia.

26 Jul 2022

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

22 Jul 2022

High-throughput, model-guided approach for rationally tuning site-specific recombination reaction

Researchers from the University of Minnesota Twin Cities have, for the first time, created a novel tool to predict and customize the rate of a particular kind of DNA editing known as “site-specific recombination.”

22 Jul 2022

Researchers discover potential ways to comprehend DNA replication

Non-coding DNA, also known as “junk DNA,” has been discovered to be anything but harmless and inactive and may even play a role in the onset of cancer.

22 Jul 2022

Study finds broadly neutralizing antibodies might help to treat or cure HIV infection

According to research, carefully formulated combinations of broadly neutralizing antibodies might effectively cure HIV while reducing the chance that the virus would evade therapy.

22 Jul 2022

Researchers find active protein in tumor cells might help in new cancer treatments

A discovery regarding how a particular protein is triggered in tumor cells, conducted by researchers at the University of California, Irvine, may lead to more effective therapies for some of the deadliest types of cancer.

20 Jul 2022

New insights into cadherin binding using high-speed atomic force microscopy

Cell-cell adhesion molecules, which link opposing cells, preserve the structure of the cell, tissue, and organ.

20 Jul 2022

Scientists demonstrate a new function of an enzyme that connects to age-related diseases

Aging and age-related diseases present a complex challenge to biomedical researchers.

20 Jul 2022

Research combines robotics and biology to create biohybrid microrobots using E. coli

A team of scientists from the Max Planck Institute for Intelligent Systems’ Physical Intelligence Department merged robotics and biology by outfitting E. coli bacteria with artificial components to create biohybrid microrobots.

From The Max Planck Institute 18 Jul 2022

Researchers discover the gene essential for the growth of photoreceptors

Srrm3 is a master regulator gene essential for the growth of photoreceptors, cells in the rear of the retina that catch and process light and transmit signals to the brain that allow vision, according to research, from the Centre for Genomic Regulation (CRG) in Barcelona.

14 Jul 2022

Cancer News and Research

Researchers create CAR T cells for cancer immunotherapy

New sample pre-treatment method enables efficient protein recovery

Optogenetic control of mitochondria–lysosome contacts induce mitochondrial fission with spatiotemporal accuracy

Research findings likely to help identify key differences between effective and flawed immune systems

SLFN11’s surveillance part in protein homeostasis

Researchers develop targeted immunotherapy to destroy tumor cells

Senior leadership positions at cancer centers lack diversity, survey reveals

Scientists determine the contribution of DNA recombinations to genomic diversity in health and disease

Scientists discover cells travel faster through mucus than blood

New method can easily convert commercially available DNA chips into RNA chips

Researchers find immune-effective ways to destroy cancer cells

New biosensor could achieve the speed, efficiency required for COVID-19 testing in future

High-throughput, model-guided approach for rationally tuning site-specific recombination reaction

Researchers discover potential ways to comprehend DNA replication

Study finds broadly neutralizing antibodies might help to treat or cure HIV infection

Researchers find active protein in tumor cells might help in new cancer treatments

New insights into cadherin binding using high-speed atomic force microscopy

Scientists demonstrate a new function of an enzyme that connects to age-related diseases

Research combines robotics and biology to create biohybrid microrobots using E. coli

Researchers discover the gene essential for the growth of photoreceptors

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics